You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
12 December 2025 - Swedish medical technology company Qlife Holding AB (STO: QLIFE), which develops the Egoo Health at-home diagnostics platform, said on Friday that its system will be used in a performance evaluation study led by Hipro Biotechnology...
12 December 2025 - BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), a US-based biotechnology company focused on treatments for hereditary angioedema (HAE) and other rare diseases, said on Friday that it has received US Food and Drug Administration appr...
12 December 2025 - Copenhagen-based biotechnology company Genmab A/S (Nasdaq: GMAB) on Friday said that all conditions to its USD97-per-share cash tender offer for Dutch oncology company Merus NV (Nasdaq: MRUS) have been satisfied, enabling acceptanc...
12 December 2025 - NanOlogy, LLC, a Texas-based, private clinical-stage oncology company, announced on Thursday that it has launched a drug development program aimed at transforming the treatment of diffuse intrinsic pontine glioma (DIPG), an aggress...
12 December 2025 - Anixa Biosciences, Inc. (NASDAQ: ANIX), a California-based biotechnology company, on Thursday announced final data from the Phase one clinical trial of its investigational breast cancer vaccine (NCT04674306) at the 2025 San Antonio...
12 December 2025 - Amgen Inc (NASDAQ:AMGN), an American multinational biopharmaceutical company, announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for its UPLIZNA (inebilizumab-cdon) intended for the t...
11 December 2025 - Physiomics plc (AIM:PYC), a mathematical modelling, data science and biostatistics company, said on Thursday that it has signed a new contract with Swiss biotechnology company Numab Therapeutics AG to support preclinical developmen...